Partner Content Partner Content Exclusive Interview with ASBM Released Ahead of Upcoming Bio... Exclusive interview with expert speaker from ASBM
Partner Content Partner Content Dr. Delma L Broussard to Speak at PFS West Coast Conference Dr. Delma L Broussard to Speak at Prefilled Syringes WC
News Working with EU is 'preferred option' post-Brexit says MHRA ... The outgoing chief executive of the UK’s drugs regulator has said that the country’s “preferred option” is to continue working with the European regulator after Brexit – although there are
News FDA rejects Nabriva's antibiotic over manufacturing concerns The FDA has rejected a proposed antibiotic from the Irish biotech Nabriva Therapeutics, citing concerns about manufacturing standards.
Partner Content Partner Content Only two weeks left until Injectable Drug Delivery Conferenc... Last chance to register
Partner Content Partner Content Clinical Development & Manufacturing Challenges for Microbio... Unresolved Challenges in Microbiome Drug Development
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
